Physician profile
Jayna Monical
NPI 1124343074
$486.61
in general payments reported to CMS, 2019-2025
14 companies · $51.64 in 2025
The $51.64 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.42 · 2023: $281 · 2024: $129 · 2025: $51.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $462.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $183.77 | 2023-2025 | |
| Lilly USA, LLC | $55.83 | 2023 | Jardiance, Emgality, Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $39.61 | 2023 | |
| Amgen INC. | $29.95 | 2023-2024 | Otezla, Repatha |
| Adlon Therapeutics L.P. | $24.42 | 2021 | |
| Ironshore Pharmaceuticals INC. | $21.46 | 2024 | |
| Phathom Pharmaceuticals, INC. | $18.69 | 2024 | Voquezna |
| Glaxosmithkline, LLC. | $16.80 | 2024 | Arexvy, Shingrix |
| Astellas Pharma US INC | $16.77 | 2023 | Veozah |
| Dexcom, INC. | $16.68 | 2023 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.55 | 2023 | |
| Sanofi Pasteur INC. | $16.55 | 2023 | |
| Janssen Pharmaceuticals, INC | $16.20 | 2023 | Xarelto |
| Exact Sciences Corporation | $13.33 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayna Monical listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.